GNR-068
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GNR-068, covering 2024-07-01 to 2025-07-30. Get the full timeline:
Most recent: Clinical Trial Update: An Efficacy and Safety Study of GNR-068 (Ustekinumab Biosimilar) and Stelara® in the Treatment of Patients With Moderate to Severe Plaque Psoriasis [Phase 3]